Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 7, 2012 - Issue
Submit an article Journal homepage
138
Views
56
CrossRef citations to date
0
Altmetric
Original Research

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids

Carl Victor Asche1 Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah;2 Center for Outcomes Research, University of Illinois College of Medicine at Peoria, Peoria, IllinoisCorrespondence[email protected]
,
Shelah Leader3 Formerly of Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey
,
Craig Plauschinat4 Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
,
Swetha Raparla1 Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah
,
Ming Yan1 Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah
,
Xiangyang Ye1 Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah
&
Dave Young1 Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah
 show all
Pages 201-209 | Published online: 15 Mar 2012

References

  • The National Heart, Lung, and Blood Institute Health Information CenterLung information http://www.nhlbi.nih.gov/health/public/lung/index.htmAccessed March 25, 2010
  • Center for Disease Control and PreventionFacts about chronic obstructive pulmonary disease (COPD) http://www.cdc.gov/copd/copdfaq.htmAccessed March 23, 2010
  • SkrepnekGHSkrepnekSVEpidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthmaAm J Manag Care7200410Suppl 5S12913815354678
  • TovarJMGumsJGMonitoring pulmonary function in asthma and COPD: point-of-care testingAnn Pharmacother200438112613314742806
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2008 update http://www.goldcopd.comAccessed March 22, 2010
  • DaimonTFujimotoKTanakaKVolume of pulmonary lobes and segments in chronic obstructive pulmonary diseases calculated using newly developed three-dimensional softwareJpn J Radiol4200927311512219412678
  • BresnitzEAEpidemiology of advanced lung disease in the United StatesClin Chest Med19971834214339329867
  • KabirZConnollyGNKohHKClancyLChronic Obstructive Pulmonary Disease hospitalization rates in Massachusetts: a trend analysisQJM2010103316316820123682
  • EdelmanNHKaplanRMBuistASChronic obstructive pulmonary disease. Task Force on Research and Education for the Prevention and Control of Respiratory DiseasesChest19921023 Suppl243S256S1516454
  • BuistASGuidelines for the management of chronic obstructive pulmonary diseaseRespir Med200296Suppl CS111612199486
  • RamseySDSuboptimal medical therapy in COPD: exploring the causes and consequencesChest20001172 Suppl33S37S10673472
  • DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
  • United States Department of LaborConsumer Price Index for Medical Care http://www.bls.gov/CPI/Accessed October 15, 2009
  • LusuardiMLucioniCDe BenedettoFMazziSSanguinettiCMDonnerCFGOLD severity stratification and risk of hospitalisation for COPD exacerbationsMonaldi Arch Chest Dis200869416416919350838
  • MiravitllesMMayordomoCArtésMSánchez-AgudoLNicolauFSegúJLTreatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitacion Obstructiva al Flujo aEreoRespir Med199993317317910464874
  • EstebanCMorazaJQuintanaJMAburtoMCapelasteguiAUse of medication and quality of life among patients with COPDRespir Med2006100348749516039840
  • López VarelaMVMuinoAPérez PadillaRTreatment of chronic obstructive pulmonary disease in 5 Latin American cities: the PLATINO studyArch Bronconeumol2008442586418361870
  • RennardSDecramerMCalverleyPMImpact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International SurveyEur Respir J200220479980512412667
  • RocheNLepageTBourcereauJTerriouxPGuidelines versus clinical practice in the treatment of chronic obstructive pulmonary diseaseEur Respir J200118690390811829094
  • GlaabTBanikNRutschmannOTWenckerMNational survey of guideline-compliant COPD management among pneumologists and primary care physiciansCOPD20063314114817240616
  • DecramerMBartschPPauwelsRYernaultJCManagement of COPD according to guidelines. A national survey among Belgian physiciansMonaldi Arch Chest Dis2003591628014533285
  • Izquierdo-AlonsoJLde Miguel-DíezJEconomic impact of pulmonary drugs on direct costs of stable chronic obstructive pulmonary diseaseCOPD20041221522317136989
  • SorianoJBVestboJPrideNBKiriVMadenCMaierWCSurvival in COPD patients after regular use of fluticasone propionate and salmeterol in general practiceEur Respir J200220481982512412670
  • CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
  • IncalziRACorsonelloAPedoneCFrom Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorderDrugs Aging200623541142016823994

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.